Johnson & Johnson Agrees to $2.5 Billion Settlement in DePuy Hip Implant Litigation: Cory Watson Crowder & DeGaris Attorney Serves on Plaintiffs' Leadership Team

Share Article

A settlement was reached in the litigation surrounding the recall of DePuy hip implants.

News Image
We are happy our clients are getting financial relief

Johnson & Johnson has agreed to pay more than $2.5 billion to resolve lawsuits involving its DePuy hip implants recalled in 2010, according to documents presented at a court hearing in the U.S. District Court for the Northern District of Ohio on November 19, 2013. The metal on metal DePuy hip implants were recalled after high failure rates were reported. Some 8,000 hip implant patients who underwent revision surgery are included in the settlement announced in court documents.The litigation is MDL no.2197 DePuy Orthopaedics, Inc., ASR Hip Implant Products Liability Litigation

“We are happy our clients are getting financial relief, though no amount of money could fully compensate them for the pain they have suffered or restore the quality of life they previously enjoyed,” said attorney Annesley H. DeGaris of Cory Watson Crowder & DeGaris. Attorneys with Cory Watson Crowder & DeGaris represent several hundred hip implant patients and DeGaris has served on the Plaintiffs’ Steering Committee in the multidistrict litigation. As reported by the FDA on August 24, 2010, DePuy Orthopaedics, Inc., a division of Johnson & Johnson, recalled the ASR™ Hip Resurfacing System and the ASR™ XL Acetabular System because of high failure rates that necessitated revision surgeries.

Cory Watson Crowder & DeGaris attorneys have been appointed to numerous leadership positions in litigation involving the failure of orthopaedic devices and have represented clients in cases involving knee replacements, hip replacements, orthopedic screws and other medical devices. Cory Watson shareholder Annesley H. DeGaris serves on the Plaintiffs’ Leadership Counsel Committee in MDL 13-2441, Stryker Rejuvenate. On July 6, 2012, the FDA announced Stryker’s recall of the Rejuvenate and ABGII hip devices and terminated distribution of the devices given the potential risks associated with “fretting and corrosion of the modular neck junction.”

Cory Watson Crowder & DeGaris is a Birmingham, Alabama law firm recognized nationally for its practice in complex litigation including multidistrict litigation, class actions, products liability, business and securities litigation, environmental litigation and mass torts litigation of defective medical devices and pharmaceutical drugs. Cory Watson has an extensive practice in consumer litigation, personal injury law and wrongful death cases. Additional information is available at

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Melanie McCraney
Follow us on
Visit website